Guggenheim Initiates Coverage On MorphoSys with Buy Rating

Guggenheim initiates coverage on MorphoSys (NASDAQ:MOR) with a Buy rating.

Benzinga · 11/20/2019 12:56

Guggenheim initiates coverage on MorphoSys (NASDAQ:MOR) with a Buy rating.